Relay Therapeutics, Inc.
RLAY
$3.20
-$0.06-1.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.25% | -5.90% | 6.27% | -1.99% | -17.72% |
| Total Depreciation and Amortization | 3.70% | 8.79% | 16.30% | 25.62% | 27.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.48% | 14.59% | 12.78% | 31.94% | 50.84% |
| Change in Net Operating Assets | 145.04% | -35.33% | -224.35% | -295.63% | -388.62% |
| Cash from Operations | 17.05% | -4.56% | -8.41% | -14.57% | -30.86% |
| Capital Expenditure | 51.09% | 66.22% | 68.08% | 51.23% | 54.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.92% | -114.42% | 1,192.50% | 2,658.44% | 245.68% |
| Cash from Investing | -115.95% | -120.39% | 2,634.93% | 18,519.39% | 236.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 677.35% | 1,980.36% | -71.82% | -71.63% | -88.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 677.35% | 1,980.36% | -71.82% | -71.63% | -88.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.71% | 100.22% | -130.75% | -119.79% | 93.82% |